| pioglitazone / Generic mfg. |
NCT00364988: Pioglitazone and Losartan Provides Additional Renoprotection |
|
|
| Completed | N/A | 60 | RoW | pioglitazone+losartan, losartan | Shanghai Jiao Tong University School of Medicine | Type 2 Diabetes, Diabetic Nephropathy | 12/05 | 01/06 | | |
NCT00419484: Effect of Pioglitazone on Cardiovascular Outcome on Higashi-Saitama Trial in Patients With Type 2 Diabetes |
|
|
| Completed | N/A | 1000 | Japan | pioglitazone | Dokkyo Medical University | Type 2 Diabetes, Hypertension, Dyslipidemia, Diabetic Nephropathy | | 07/08 | | |
NCT00586261: Does Thiazolidinedione Therapy Improve Endothelial Function and Preserve Renal Function |
|
|
| Terminated | N/A | 36 | US | Pioglitazone, Actos, Placebo, Nitroglycerin, Nitrostat | Mayo Clinic | Chronic Kidney Disease | 01/09 | 07/09 | | |
NCT00745914: Peroxisome Proliferator-Activated Receptor-gamma (PPAR-gamma) Agonist in Diabetic End-Stage Renal Disease Patients |
|
|
| Completed | N/A | 22 | RoW | Pioglitazone, Actos, Placebo comparator, Placebo | The University of Hong Kong | Endstage Renal Disease, Diabetes | 09/13 | 12/13 | | |
NCT01637935: Cohort Study of Pioglitazone and Bladder Cancer in Patients With Type II Diabetes |
|
|
| Completed | N/A | 193099 | NA | Pioglitazone, Actos | Takeda, Kaiser Permanente, Department of Epidemiology at University of Pennsylvania | Diabetes, Bladder Cancer | 08/14 | 08/14 | | |
| Completed | N/A | 95 | US | Pioglitazone, Actos, Placebo | University of Utah, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), University of Colorado, Denver | End Stage Renal Disease | 12/15 | 12/15 | | |
